Insulet (PODD) News Today $304.63 +1.01 (+0.33%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$299.26 -5.37 (-1.76%) As of 06/13/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PODD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Insulet (NASDAQ:PODD) Stock Rating Lowered by Wall Street ZenWall Street Zen downgraded Insulet from a "buy" rating to a "hold" rating in a research report on Saturday.June 14 at 2:03 AM | marketbeat.comAssenagon Asset Management S.A. Has $24.12 Million Stock Holdings in Insulet Co. (NASDAQ:PODD)Assenagon Asset Management S.A. decreased its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 12.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 91,836 shares of the medical instruments supplier's stocJune 13 at 4:35 AM | marketbeat.comHandelsbanken Fonder AB Increases Holdings in Insulet Co. (NASDAQ:PODD)Handelsbanken Fonder AB grew its stake in Insulet Co. (NASDAQ:PODD - Free Report) by 7.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,316 shares of the medical instruments supplier's stock after purchasingJune 13 at 4:34 AM | marketbeat.comInsulet Co. (NASDAQ:PODD) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Insulet Co. (NASDAQ:PODD - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seventeen research firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and fourteen have issued a buy raJune 12 at 4:19 AM | marketbeat.comInsulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 CompatibilityJune 11 at 6:02 PM | finance.yahoo.comIntegrated Advisors Network LLC Lowers Position in Insulet Co. (NASDAQ:PODD)Integrated Advisors Network LLC cut its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 41.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,229 shares of the medical instruments supplier's stoJune 11 at 6:30 AM | marketbeat.comInsulet Director Cashes In on Stock Sale!June 10, 2025 | tipranks.comInsider Sell: Luciana Borio Sells Shares of Insulet Corp (PODD)June 10, 2025 | gurufocus.comInsulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. UsersJune 10, 2025 | finance.yahoo.comInsulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. UsersJune 10, 2025 | businesswire.comPODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod AdoptionJune 10, 2025 | msn.comInsulet Corporation (PODD) Announces Credit Agreement Refinancing and Convertible Notes RedemptionJune 9, 2025 | gurufocus.com3 Medical Technology Stocks Outperforming in 2025Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.June 9, 2025 | marketbeat.comCongress Asset Management Co. Acquires 9,916 Shares of Insulet Co. (NASDAQ:PODD)Congress Asset Management Co. increased its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 15.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 75,439 shares of the medical instruments supplier's stock afterJune 8, 2025 | marketbeat.comQ1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top MarksJune 6, 2025 | msn.comTD Cowen Raises Insulet (PODD) Price Target, Maintains Buy RatingJune 5, 2025 | insidermonkey.comContravisory Investment Management Inc. Increases Holdings in Insulet Co. (NASDAQ:PODD)Contravisory Investment Management Inc. lifted its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 50.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,186 shares of the medical instruments supplier'sJune 4, 2025 | marketbeat.comCzech National Bank Boosts Holdings in Insulet Co. (NASDAQ:PODD)Czech National Bank increased its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 5.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,111 shares of the medical instruments supplier's stock after buying an additional 902 shares duringJune 4, 2025 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Purchased by Rhumbline AdvisersRhumbline Advisers boosted its position in Insulet Co. (NASDAQ:PODD - Free Report) by 7.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 152,882 shares of the medical instruments suppliJune 4, 2025 | marketbeat.comReflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)June 3, 2025 | msn.comAEGON ASSET MANAGEMENT UK Plc Lowers Stake in Insulet Co. (NASDAQ:PODD)AEGON ASSET MANAGEMENT UK Plc reduced its position in Insulet Co. (NASDAQ:PODD - Free Report) by 20.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,806 shares of the medical instruments supplier'June 3, 2025 | marketbeat.com1 Surging Stock with Exciting Potential and 2 to QuestionJune 2, 2025 | finance.yahoo.comGoldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech SurgesJune 2, 2025 | benzinga.comGoldman Sachs Initiates Coverage of Insulet (PODD) with Buy RatingMay 31, 2025 | insidermonkey.comInsulet (NASDAQ:PODD) Earns Buy Rating from Analysts at The Goldman Sachs GroupThe Goldman Sachs Group started coverage on Insulet in a research note on Friday. They set a "buy" rating and a $380.00 price target for the company.May 31, 2025 | marketbeat.comGAMMA Investing LLC Has $1.74 Billion Stock Position in Insulet Co. (NASDAQ:PODD)GAMMA Investing LLC raised its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 27,298.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 664,141 shares of the medical instruments supplier'May 31, 2025 | marketbeat.comCalifornia State Teachers Retirement System Decreases Holdings in Insulet Co. (NASDAQ:PODD)California State Teachers Retirement System trimmed its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 99,976 shares of the medical instruments suMay 31, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of Insulet (PODD) with Buy RecommendationMay 31, 2025 | msn.comInsulet (NASDAQ:PODD) Upgraded by Wall Street Zen to "Buy" RatingWall Street Zen raised shares of Insulet from a "hold" rating to a "buy" rating in a research report on Friday.May 31, 2025 | marketbeat.comGoldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at BuyMay 30, 2025 | finance.yahoo.comGoldman Sachs Initiates Coverage on Insulet (PODD) with Buy Rating | PODD Stock NewsMay 30, 2025 | gurufocus.comUniversal Beteiligungs und Servicegesellschaft mbH Buys Shares of 114,883 Insulet Co. (NASDAQ:PODD)Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Insulet Co. (NASDAQ:PODD - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 114,883 shares of the medical instrumentMay 30, 2025 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Purchased by Toronto Dominion BankToronto Dominion Bank boosted its stake in Insulet Co. (NASDAQ:PODD - Free Report) by 55.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,486 shares of the medical instruments supplier's stock after acquiring an additional 12,984 shares during thMay 30, 2025 | marketbeat.comGoldman Sachs Initiates Coverage on Insulet (PODD) with Positive Outlook | PODD Stock NewsMay 29, 2025 | gurufocus.comInsulet Shows Market Leadership With Jump To 95 RS RatingMay 29, 2025 | msn.comIs Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?May 29, 2025 | finance.yahoo.comTwo Sigma Investments LP Sells 22,134 Shares of Insulet Co. (NASDAQ:PODD)Two Sigma Investments LP decreased its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 56.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,978 shares of the medical instruments supplier's stock after selling 22,134 shares during thMay 29, 2025 | marketbeat.comInsulet Corporation (PODD) Announces Approval of 2025 Stock Option and Incentive PlanMay 28, 2025 | gurufocus.comInsulet Corporation: Shares Remain Astronomically ExpensiveMay 28, 2025 | seekingalpha.comRaymond James Raises Insulet (NASDAQ:PODD) Price Target to $360.00Raymond James raised their price objective on shares of Insulet from $328.00 to $360.00 and gave the stock an "outperform" rating in a report on Tuesday.May 28, 2025 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Bought by Azzad Asset Management Inc. ADVAzzad Asset Management Inc. ADV raised its position in Insulet Co. (NASDAQ:PODD - Free Report) by 13.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,161 shares of the medical instruments supplierMay 28, 2025 | marketbeat.comAmerican Trust Makes New $210,000 Investment in Insulet Co. (NASDAQ:PODD)American Trust acquired a new position in Insulet Co. (NASDAQ:PODD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 805 shares of the medical instruments supplier's stock, valued at approximately $210,000. SeMay 28, 2025 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Bought by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio grew its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 29.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 33,063 shares of the medical instruments supplier's stock after acqMay 28, 2025 | marketbeat.comIntegrated Advisors Network LLC Acquires 7,616 Shares of Insulet Co. (NASDAQ:PODD)Integrated Advisors Network LLC grew its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 13.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 65,769 shares of the medical instrumentsMay 27, 2025 | marketbeat.comPolar Asset Management Partners Inc. Sells 6,400 Shares of Insulet Co. (NASDAQ:PODD)Polar Asset Management Partners Inc. cut its holdings in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 217,642 shares of the mediMay 27, 2025 | marketbeat.comGF Fund Management CO. LTD. Buys Shares of 1,683 Insulet Co. (NASDAQ:PODD)GF Fund Management CO. LTD. bought a new position in Insulet Co. (NASDAQ:PODD - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,683 shares of the medical instruments supplier's stock, valued atMay 27, 2025 | marketbeat.comPeak Retirement Planning Inc. Buys Shares of 4,070 Insulet Co. (NASDAQ:PODD)Peak Retirement Planning Inc. bought a new stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 4,070 shares of the medical instruments supplier's stock, valued at approximately $1,063,000. OtherMay 26, 2025 | marketbeat.comJT Stratford LLC Invests $257,000 in Insulet Co. (NASDAQ:PODD)JT Stratford LLC acquired a new position in shares of Insulet Co. (NASDAQ:PODD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 986 shares of the medical instruments supplier's stock, valued at approximately $257,000. Other institutiMay 25, 2025 | marketbeat.com847 Shares in Insulet Co. (NASDAQ:PODD) Purchased by Cornerstone Advisory LLCCornerstone Advisory LLC bought a new stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 847 shares of the medical instruments supplier's stock, vMay 25, 2025 | marketbeat.comInsulet (NASDAQ:PODD) Reaches New 1-Year High - Here's WhyInsulet (NASDAQ:PODD) Reaches New 52-Week High - Should You Buy?May 24, 2025 | marketbeat.com Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address PODD Media Mentions By Week PODD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PODD News Sentiment▼0.920.88▲Average Medical News Sentiment PODD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PODD Articles This Week▼1513▲PODD Articles Average Week Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Becton, Dickinson and Company News Edwards Lifesciences News IDEXX Laboratories News ResMed News DexCom News STERIS News Baxter International News Hologic News Masimo News Globus Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PODD) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insulet Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insulet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PODD Stock Free PODD Stock Alerts